IMFINZI 50 mg/mL concentrate for solution for infusion.
TRADE-hypo
Phase 2 small_molecule active
Quick answer
IMFINZI 50 mg/mL concentrate for solution for infusion. for unresectable stage III NSCLC (Non–small-cell lung cancer) is a Phase 2 program (small_molecule) at Institut für biomedizinische Analytik NMR-Imaging GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Institut für biomedizinische Analytik NMR-Imaging GmbH
- Indication
- unresectable stage III NSCLC (Non–small-cell lung cancer)
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active